Callan Capital LLC Raises Position in Haleon plc (NYSE:HLN)

Callan Capital LLC increased its holdings in Haleon plc (NYSE:HLN) by 30.0% during the fourth quarter, Holdings Channel.com reports. The firm owned 36,266 shares of the company’s stock after acquiring an additional 8,359 shares during the quarter. Callan Capital LLC’s holdings in Haleon were worth $346,000 at the end of the most recent quarter.

Other large investors also recently added to or reduced their stakes in the company. Sierra Ocean LLC purchased a new position in Haleon in the 4th quarter worth $26,000. Fortitude Family Office LLC bought a new stake in Haleon in the 3rd quarter worth $28,000. Versant Capital Management Inc grew its holdings in Haleon by 2,029.1% in the 4th quarter. Versant Capital Management Inc now owns 3,513 shares of the company’s stock worth $34,000 after acquiring an additional 3,348 shares during the last quarter. Geneos Wealth Management Inc. bought a new stake in Haleon in the 4th quarter worth $35,000. Finally, Toronto Dominion Bank grew its holdings in Haleon by 3,470.0% in the 3rd quarter. Toronto Dominion Bank now owns 3,570 shares of the company’s stock worth $38,000 after acquiring an additional 3,470 shares during the last quarter. Hedge funds and other institutional investors own 6.67% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on HLN shares. Morgan Stanley lowered shares of Haleon from an “overweight” rating to an “equal weight” rating in a report on Friday, January 10th. Sanford C. Bernstein lowered shares of Haleon from an “outperform” rating to a “market perform” rating in a report on Wednesday, January 8th. Three investment analysts have rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, Haleon currently has an average rating of “Moderate Buy” and a consensus price target of $10.95.

Haleon Trading Up 1.8 %

Shares of HLN opened at $10.08 on Friday. The firm’s 50-day moving average price is $9.56 and its 200-day moving average price is $9.82. The firm has a market capitalization of $45.61 billion, a price-to-earnings ratio of 29.63, a PEG ratio of 2.82 and a beta of 0.28. The company has a current ratio of 0.84, a quick ratio of 0.58 and a debt-to-equity ratio of 0.44. Haleon plc has a 1-year low of $7.89 and a 1-year high of $10.80.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.